Design Therapeutics: Funding, Investors & Team (Sep 2026)
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company’s lead program is focused on the treatment of Friedreich’s ataxia and discovery efforts are ongoing in other degenerative diseases.
Design Therapeutics has raised $125M across 1 funding round on record, the most recent a Series B of $125M announced in Jan 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Design Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2021.
Design Therapeutics Funding Rounds
Design Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Design Therapeutics Funding Compared to Other Biotechnology Startups
Design Therapeutics' latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Design Therapeutics in Biotechnology and Solana Beach
Companies Similar to Design Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Design Therapeutics Funding FAQs
What does Design Therapeutics do?
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company’s lead program is focused on the treatment of Friedreich’s ataxia and discovery efforts are ongoing in other degenerative diseases.
How much funding has Design Therapeutics raised?
Design Therapeutics has raised $125M across 1 round on record. The most recent is a Series B of $125M announced in Jan 2021.
When did Design Therapeutics last raise funding?
Design Therapeutics' most recent funding round on record is a Series B of $125M, announced in Jan 2021.
Who is the CEO of Design Therapeutics?
Joao Siffert is listed as CEO at Design Therapeutics.
Where is Design Therapeutics headquartered?
Design Therapeutics is based in Solana Beach, California, United States.
How many employees does Design Therapeutics have?
Design Therapeutics is in the 11-50 employee band.
How does Design Therapeutics' funding compare to other Biotechnology startups?
Design Therapeutics' latest round of $125M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Design Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Design Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.